sk&f 86002 has been researched along with Endotoxemia in 1 studies
6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole: inhibits p38 MAP kinase
Endotoxemia: A condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Triplett, EA | 1 |
Kruse-Elliott, KT | 1 |
Hart, AP | 1 |
Schram, BR | 1 |
MacWilliams, PS | 1 |
Cooley, AJ | 1 |
Clayton, MK | 1 |
Darien, BJ | 1 |
1 other study available for sk&f 86002 and Endotoxemia
Article | Year |
---|---|
SK&F 86002, a dual cytokine and eicosanoid inhibitor, attenuates endotoxin-induced cardiopulmonary dysfunction in the pig.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Eicosanoids; Endotoxemia; Heart; Imidaz | 1996 |